|Type of Transaction||Buyout / Growth Capital|
B Healthcare Investments (BHI) was established in 2021 to invest in the specialized healthcare sector in Egypt. The company aims to target businesses that are led by solid and reputable medical teams and are well-positioned for growth.
BHI will focus on investing in several key fertility centers that strategically located across Egypt. These centers will act as regional fertility hubs and catalysts for growth to reach a critical mass of 12–15K in vitro fertilization (IVF) cycles and capture a significant market share in the Egyptian Assisted Reproductive Technology (ART) market. BHI also aims to invest in other specialized healthcare fields.
In 2022, BHI acquired 51% of The Egyptian IVF Center, a pioneer of in-vitro fertilization (IVF) and one of the leading fertility centers in Egypt and the wider MENA region.
BHI will be targeting investments in well-established, successful companies with stable cash flows, healthy profitability margins, and significant growth potential, including organic growth and acquisition, while shying away from greenfield and turnaround investments